Drug detailing in academic medical centers: regulating for the right reasons, with the right evidence, at the right time.
作者信息
Steinman Michael A, Schillinger Dean
机构信息
University of California, San Francisco, CA, USA.
出版信息
Am J Bioeth. 2010 Jan;10(1):21-3. doi: 10.1080/15265160903441103.
Abstract
摘要
相似文献
1
Drug detailing in academic medical centers: regulating for the right reasons, with the right evidence, at the right time.学术医疗中心的药品推广：基于正确的理由、凭借正确的证据、在正确的时间进行规范。
Am J Bioeth. 2010 Jan;10(1):21-3. doi: 10.1080/15265160903441103.
2
The details are in the field.细节就在该领域中。
Am J Bioeth. 2010 Jan;10(1):19-21. doi: 10.1080/15265160903460921.
3
Avoiding over-deterrence in managing physicians' relationships with industry.在管理医生与行业的关系时避免过度威慑。
Am J Bioeth. 2010 Jan;10(1):27-9. doi: 10.1080/15265160903441129.
4
Drug detailers, professionalism, and prudence.药品推销员、专业素养与审慎态度。
Am J Bioeth. 2010 Jan;10(1):9-10. doi: 10.1080/15265160903441020.
5
Contact with pharmaceutical representatives: where does prudence lead?与医药代表接触：审慎会指向何方？
Am J Bioeth. 2010 Jan;10(1):11-3. doi: 10.1080/15265160903441046.
6
The AAMC exhibits the behavior it condemns.美国医学院协会表现出了它所谴责的行为。
Am J Bioeth. 2010 Jan;10(1):26-7. doi: 10.1080/15265160903441095.
7
The devil in the detail(ing).细节决定成败。
Am J Bioeth. 2010 Jan;10(1):15-7. doi: 10.1080/15265160903460905.
8
Why academic medical centers should ban drug company gifts to individuals.学术医疗中心为何应禁止制药公司向个人赠送礼品。
Am J Bioeth. 2010 Jan;10(1):13-5. doi: 10.1080/15265160903441061.
9
The pitfalls of misreading: what does "industry funding of medical education" actually say?误读的陷阱：“医学教育的行业资助”究竟意味着什么？
Am J Bioeth. 2010 Jan;10(1):24-5. doi: 10.1080/15265160903441038.
10
Response to open peer commentaries on "The pitfalls of deducing ethics from economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing".对关于“从经济学推导伦理学的陷阱：为何美国医学院协会在医药推广方面的观点是错误的”的公开同行评论的回应
Am J Bioeth. 2010 Jan;10(1):W1-3. doi: 10.1080/15265160903493088.
本文引用的文献
1
Following the script: how drug reps make friends and influence doctors.照章行事：医药代表如何结交并影响医生。
PLoS Med. 2007 Apr;4(4):e150. doi: 10.1371/journal.pmed.0040150.
2
Narrative review: the promotion of gabapentin: an analysis of internal industry documents.叙述性综述：加巴喷丁的推广：对行业内部文件的分析
Ann Intern Med. 2006 Aug 15;145(4):284-93. doi: 10.7326/0003-4819-145-4-200608150-00008.
3
The effects and role of direct-to-physician marketing in the pharmaceutical industry: an integrative review.直接面向医生的营销在制药行业中的影响与作用：一项综合综述
Yale J Health Policy Law Ethics. 2005 Summer;5(2):785-822.
4
Interactions between pharmaceutical representatives and doctors in training. A thematic review.实习医生与医药代表之间的互动：一项专题综述
J Gen Intern Med. 2005 Aug;20(8):777-86. doi: 10.1111/j.1525-1497.2005.0134.x.
5
Synergy between publication and promotion: comparing adoption of new evidence in Canada and the United States.出版物与推广之间的协同作用：加拿大和美国新证据采用情况比较
Am J Med. 2003 Oct 15;115(6):467-72. doi: 10.1016/s0002-9343(03)00422-4.
6
Medical professionalism--focusing on the real issues.医学职业精神——关注实际问题。
N Engl J Med. 2000 Apr 27;342(17):1284-6. doi: 10.1056/NEJM200004273421711.
7
Physicians and the pharmaceutical industry: is a gift ever just a gift?医生与制药行业：礼物仅仅只是礼物吗？
JAMA. 2000 Jan 19;283(3):373-80. doi: 10.1001/jama.283.3.373.
Zotero 插件